Open-Label, Multicenter Extension Study for Patients Completing Treatment Phase of a Rigel-Sponsored R935788 Studies
Public ClinicalTrials.gov record NCT00805467. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label, Multicenter Extension Study to Evaluate the Safety of R935788 in Patients With Rheumatoid Arthritis Who Have Completed the Treatment Phase of a Rigel-Sponsored R935788 Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this new research study is to gain additional information about how safe and effective R935788 is over a longer period of time.
Study identification
- NCT ID
- NCT00805467
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 624 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2008
- Primary completion
- Jul 31, 2013
- Completion
- Jul 31, 2013
- Last update posted
- Jun 24, 2014
2008 – 2013
United States locations
- U.S. sites
- 35
- U.S. states
- 17
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | La Jolla | California | — | — |
| Research Site | Palm Desert | California | — | — |
| Research Site | Palo Alto | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Santa Maria | California | — | — |
| Research Site | Hamden | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Aventura | Florida | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Ocala | Florida | — | — |
| Research Site | Orange Park | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | South Miami | Florida | — | — |
| Research Site | Venice | Florida | — | — |
| Research Site | Boise | Idaho | — | — |
| Research Site | Coeur d'Alene | Idaho | — | — |
| Research Site | South Bend | Indiana | — | — |
| Research Site | Elizabethtown | Kentucky | — | — |
| Research Site | Cumberland | Maryland | — | — |
| Research Site | Hagerstown | Maryland | — | — |
| Research Site | Lansing | Michigan | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Roslyn | New York | — | — |
| Research Site | Smithtown | New York | — | — |
| Research Site | Raleigh | North Carolina | — | — |
| Research Site | Mayfiled Village | Ohio | — | — |
| Research Site | Erie | Pennsylvania | — | — |
| Research Site | Willow Grove | Pennsylvania | — | — |
| Research Site | Wyomissing | Pennsylvania | — | — |
| Research Site | Jackson | Tennessee | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Oklahoma City | Washington | — | — |
| Research Site | Spokane | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00805467, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00805467 live on ClinicalTrials.gov.